Skip to content
Trial Eligibility
Menu

Spermatogonial Differentiation Via Testicular Organoid

NCT06841861

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Purpose: This clinical trial aims to explore the potential for human sperm production in vitro by sustaining a laboratory-cultured adult testicular environment. It also seeks to identify genetic factors contributing to human sterility and failed spermatogenesis. The study's primary objectives include: Identifying genomic markers associated with sterility and failed spermatogenesis. Developing an ex vivo (outside the body) testis "organ-on-a-chip" ("iTestis") to support stem cell cultivation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Infertility, Male
  • Gene Abnormality
  • Sterility, Male

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1/2
Ages
18 to 60 years
Sex
Male
Healthy volunteers
Accepted
Sponsor
CellARTs Inc.
Last updated on ClinicalTrials.gov
February 24, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • The Turek Clinic · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.